[Nephrogenic systemic fibrosis]
- PMID: 18264914
[Nephrogenic systemic fibrosis]
Abstract
Nephrogenic systemic fibrosis (NSF) is a new, rare, and severe disease occurring in patients with renal failure who have been exposed to gadolinium. The pathogenesis of NSF is not completely known. In fact, the first warning about a significant relationship between NSF and gadolinium (a contrast medium used in magnetic resonance imaging) was only issued in 2006. No cases of NSF have been reported in Italy to date. A nationwide investigation should therefore be carried out to assess the real prevalence of NSF within the Italian uremic population. Furthermore, we need guidelines to reduce the risk of NSF in renal patients undergoing MRI with contrast medium.
Comment in
-
[Gadolinium: a true problem for the nephrologists?].G Ital Nefrol. 2008 Jan-Feb;25(1):3-4. G Ital Nefrol. 2008. PMID: 18264906 Italian. No abstract available.
Similar articles
-
Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.Am J Kidney Dis. 2008 Jun;51(6):966-75. doi: 10.1053/j.ajkd.2007.12.036. Epub 2008 Mar 25. Am J Kidney Dis. 2008. PMID: 18501784
-
[Gadolinium: a true problem for the nephrologists?].G Ital Nefrol. 2008 Jan-Feb;25(1):3-4. G Ital Nefrol. 2008. PMID: 18264906 Italian. No abstract available.
-
MRI gadolinium-based contrast agents. Radiologists beware!Ann Pharm Fr. 2009 Sep;67(5):335-9. doi: 10.1016/j.pharma.2009.06.002. Epub 2009 Jul 23. Ann Pharm Fr. 2009. PMID: 19695369 Review.
-
Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.J Nephrol. 2008 May-Jun;21(3):324-36. J Nephrol. 2008. PMID: 18587720 Review.
-
Extracellular Gd-CA: differences in prevalence of NSF.Eur J Radiol. 2008 May;66(2):180-3. doi: 10.1016/j.ejrad.2008.01.024. Epub 2008 Mar 14. Eur J Radiol. 2008. PMID: 18342468 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical